Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000276289 | SCV000402213 | likely benign | Nephropathic cystinosis | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000333816 | SCV000402214 | likely benign | Ocular cystinosis | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Center for Pediatric Genomic Medicine, |
RCV000440461 | SCV000511221 | benign | not provided | 2016-10-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002512765 | SCV000751434 | benign | Ocular cystinosis; Juvenile nephropathic cystinosis; Inborn genetic diseases | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000276289 | SCV001140213 | likely benign | Nephropathic cystinosis | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000440461 | SCV001840655 | benign | not provided | 2019-04-20 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 15128704, 10556299, 20981092, 24123366) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001699175 | SCV002050958 | likely benign | not specified | 2021-12-10 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000440461 | SCV005217949 | likely benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000004700 | SCV000024875 | pathogenic | Cystinosis, atypical nephropathic | 1999-12-01 | no assertion criteria provided | literature only | |
Natera, |
RCV001276655 | SCV001463145 | benign | Cystinosis | 2020-09-16 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001699175 | SCV001926683 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001699175 | SCV001952513 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003914807 | SCV004731501 | benign | CTNS-related disorder | 2019-07-01 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |